PRECEDE BIO
LIVE

Serial Number

98391991

Owner

Precede Biosciences, Inc.

Attorney

Caitlin R. Byczko

Filing Date

Feb 5, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PRECEDE BIO Trademark

Serial Number: 98391991

PRECEDE BIO is a trademark filed by Precede Biosciences, Inc. on February 5, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Precede Biosciences, Inc.

1 Design Center Place, 5th Floor
Boston, MA 02210

Entity Type: 03

Trademark Details

Filing Date

February 5, 2024

Registration Date

Not Registered

Published for Opposition

January 14, 2025

Goods & Services

medical testing and diagnostic services; clinical pathology services, namely, medical pathology services; medical analysis services for diagnostic and treatment purposes relating to the treatment of persons in the nature of genomic and epigenomic profiling of human biological samples; medical testing for diagnostic or treatment purposes in the field of pathology relating to the treatment of persons; medical diagnostic testing, monitoring and reporting services; diagnostics services, namely, the recommendation of medical treatment for identified disease states

Software as a service (SAAS) services featuring software for inputting, accessing, viewing, processing and analyzing medical data; data as a service (DAAS) services featuring non-downloadable software for the provision of data, namely, for inputting, accessing, viewing, processing and analyzing medical data; computer services, namely, providing data as a service (DaaS) services featuring non-downloadable software for analyzing and managing data for purposes of drug development and discovery; computer services, namely, the provision of data as a service (DaaS) in the pharmaceuticals and healthcare fields for analyzing medical research data information in relation to pharmaceutical drug discovery and drug development; pharmaceutical research and development; pharmaceutical drug development and drug discovery services; medical research and scientific research; providing medical and scientific research information in the field of pharmaceuticals research and development of technology in the field of pharmaceuticals; biomedical research services; product development in the field of pharmaceuticals, namely, the development of preclinical and therapeutic product

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 11, 2026 EXRA
SOU EXTENSION 2 GRANTED
Mar 10, 2026 EX2G
SOU EXTENSION 2 FILED
Mar 10, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 10, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2025 EXRA
SOU EXTENSION 1 GRANTED
Aug 19, 2025 EX1G
SOU EXTENSION 1 FILED
Aug 19, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 19, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 11, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 14, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 14, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 8, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 20, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 26, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 26, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 4, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 4, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 4, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 29, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2024 NWOS
NEW APPLICATION ENTERED
Feb 5, 2024 NWAP